Do You Still Get Hungry on Wegovy?

Wegovy (semaglutide) reduces appetite by acting on GLP-1 receptors — it does not switch hunger off completely, but most people experience a noticeably reduced drive to eat.
The degree of hunger suppression tends to increase with each dose step, so early weeks on a lower dose often feel less dramatic than later stages of treatment.
Some hunger (particularly at certain times of day or linked to habit and emotion) can persist throughout treatment, and recognising this helps you manage it.
If hunger feels unchanged after several weeks on your maintenance dose, your prescriber should know, it may point to a missed dose, an absorption issue, or a need to review the plan.

Yes, some hunger usually remains on Wegovy — it is reduced, not eliminated. Semaglutide lowers appetite by acting on GLP-1 receptors in the brain and gut, slowing how quickly your stomach empties and signalling fullness sooner. Most people find they stop thinking about food as often, but hunger does not disappear entirely, and that is normal. These are prescription-only medicines; a prescriber assesses whether Wegovy is clinically suitable for you before treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How hunger changes across Wegovy treatment, and what to do when it does not

Your first few weeks: the appetite shift is real, but gradual

Picture the first Monday after your initial Wegovy injection. You sit down to lunch and notice you are halfway through your plate and simply not interested in the rest. That is the GLP-1 effect working, gastric emptying slows, and satiety signals reach the brain earlier than they used to. For most people, this shift starts at the lower doses and becomes more pronounced as the dose increases over the following months.

That said, hunger does not vanish. Many people describe it as quieter rather than absent, a background murmur instead of the loud, insistent signal they were used to. Early in treatment, at the 0.25mg or 0.5mg stages, the change can feel subtle. This is by design: the titration schedule exists partly to let your body adapt, not to suppress appetite fully from day one. The full picture of how Wegovy works explains this dose-by-dose journey in more detail.

The practical upshot: if you are in your first four to eight weeks and still feeling hungry at the 0.5mg stage, that is expected and well within the normal range for this point in the titration. Give the process time, and keep notes on when hunger is strongest, that pattern matters later.

Why some hunger sticks around even at higher doses

There are a few distinct kinds of hunger, and Wegovy addresses them differently. If you are curious about whether you should expect to feel hungry on Wegovy at all, the short answer is that physiological hunger, the stomach-growling kind driven by your body genuinely needing fuel, tends to be significantly blunted by semaglutide. The STEP 1 trial, published in the New England Journal of Medicine, reported an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, which reflects real, sustained appetite change at a population level.

Emotional and habitual hunger are a different matter. The urge to eat because you are bored, stressed, tired, or simply because it is 8pm and the television is on does not have the same biological root. Semaglutide does not fully rewire those cues. Many people on Wegovy find that emotional eating patterns need separate, deliberate attention alongside the medicine.

There is also the question of timing. Hunger often returns more noticeably in the final day or two before your next weekly injection, as semaglutide levels in the blood naturally fall. This is not a sign the medicine has stopped working. It is pharmacokinetics. Noting which day of the week this happens and adjusting what you eat on those days can make a real difference.

What to eat when hunger does return

The appetite reduction Wegovy creates is most useful when the food you do eat is doing real work. Because you are eating less overall, protein becomes more important, not less, it preserves muscle mass and keeps you fuller for longer. Eating well on Wegovy covers this in detail, but the short version is: lean protein, vegetables with fibre, and enough water.

Some people experience what feels like increased hunger shortly after eating, this can actually be a sign of low blood sugar following a fast gastric response, rather than true appetite. Eating more slowly, choosing lower-glycaemic-index foods, and avoiding very sugary snacks helps here. The NHS semaglutide guidance recommends pairing Wegovy with a reduced-calorie diet and increased activity for exactly this reason: the medicine changes the appetite signal, but your habits shape what you do with that signal.

If you are genuinely unsure whether the hunger you are feeling is normal at your current dose, that is worth raising with a prescriber. You should never try to self-manage by adjusting your dose or timing.

When persistent hunger is a flag worth raising

If hunger feels entirely unchanged after several weeks at your current dose (not just present, but no different from before you started) that is worth discussing. A few things could explain it. The injection technique might need checking (injecting into scar tissue or muscle rather than fat reduces absorption). A dose that has been stored incorrectly can lose potency. Or the dose may simply need reviewing by the prescriber, which is a routine part of ongoing treatment.

We hear this from patients fairly regularly: they assumed persistent hunger meant the medicine was not working for them personally, when a straightforward technique adjustment resolved it. If you are at a point where you feel still hungry on Wegovy despite doing everything right, do not quietly stop treatment without speaking to a clinician first.

Honest acknowledgement: if you are reading this because you are frustrated (you expected more of a change and it has not quite arrived) that is an understandable place to be. Most people do see a meaningful shift, but the timeline is not identical for everyone, and the medicine works best as part of a supported clinical plan rather than in isolation. If you want to talk through where you are in treatment, our prescribers are available seven days a week. Speak to our prescribers to start a free consultation or to review how things are going.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions